Terms: = Kidney tumors AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43 AND Prognosis
3 results:
1. The up-regulation of ndrg1 by HIF counteracts the cancer-promoting effect of HIF in VHL-deficient clear cell renal cell carcinoma.
Zhang ZY; Zhang SL; Chen HL; Mao YQ; Li ZM; Kong CY; Han B; Zhang J; Chen YH; Xue W; Zhai W; Wang LS
Cell Prolif; 2020 Jul; 53(7):e12853. PubMed ID: 32537867
[TBL] [Abstract] [Full Text] [Related]
2. Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy.
Zargar-Shoshtari K; Zargar H; Dinney CP; Ercole CE; Sharma P; Kovac E; Grivas PD; Stephenson AJ; Shah JB; Black PC; Spiess PE
World J Urol; 2016 May; 34(5):695-701. PubMed ID: 26286880
[TBL] [Abstract] [Full Text] [Related]
3. Proteomics identified nuclear N-myc downstream-regulated gene 1 as a prognostic tissue biomarker candidate in renal cell carcinoma.
Hosoya N; Sakumoto M; Nakamura Y; Narisawa T; Bilim V; Motoyama T; Tomita Y; Kondo T
Biochim Biophys Acta; 2013 Dec; 1834(12):2630-9. PubMed ID: 23999030
[TBL] [Abstract] [Full Text] [Related]
